Lymphadenopathy is one of the leading and persistent signs during the progression of human immunodeficiency virus (HIV) infection. Lymphadenopathy, as a clinical sign, can become one of the important guiding tools for detecting hidden HIV-positive cases. The present study was conducted to assess the incidence of HIV positivity in previously undiagnosed patients of HIV presenting with lymphadenopathy, comparing it with the current trends of HIV infection in the community, and to ascertain the etiology of lymphadenopathy in HIV-positive and HIV-negative cases. Over a period of 6 years, a total of 1082 cases of extra-inguinal lymphadenopathy were screened for HIV infection. Simultaneously, fine needle aspiration cytology of the enlarged lymph nodes was performed to know the etiology. The incidence of HIV positivity was found to be 2.3% among the patients presenting with lymphadenopathy. Among the HIV-positive cases, tuberculous lymphadenopathy was found in 60% of cases as compared to 28% of cases in HIV-negative cases. Alarmingly high incidence of HIV infection among the lymphadenopathy cases has been observed. This necessitates the importance of exercising vigilance, caution, and a high degree of suspicion while dealing with patients of lymphadenopathy, to protect ourselves as well as a much larger population at risk from this scourge.
AIDS was discovered in the summer of 1981 in the United States. No one knows how many people developed AIDS in the 1970s or, indeed, in the years before. Neither do we know, nor will we probably ever know, where the AIDS virus originated. In the first World Health Organization (WHO) meeting in Denmark in October 1983, it was reported that there had been 2803 AIDS cases in the United States. By the end of 1986, 85 countries had reported 38 401 cases of AIDS to WHO, and by December 2005, there were a total of 40.3 million cases (38.0 million adults and 2.3 million children) living with HIV. During 2005, some 4.9 million people became infected with HIV, and the year also saw 3.1 million deaths from AIDS.
1 Such a rising incidence of AIDS is due to the fact that HIV infection is not accompanied by signs and symptoms salient enough to be noticed and, hence, an HIV-infected person unknowingly spreads the infection to other people.
As the HIV virus primarily infects the lymphocytes, lymph nodes are commonly involved during all stages of infection and are one of the earliest signs in HIVinfected patients. According to the US Centers for Disease Control and Prevention classification of the clinical course of HIV and AIDS, there are 4 stages of progression of HIV infection.
2 Stage I is the seroconversion stage, which persists for about 1 to 3 months, and during this period, 50% of HIV-infected individuals suffer from fever, myalgia, arthralgia, headache, lymphadenopathy, skin rash, and so on. Stage II is the long asymptomatic stage of about 8 to 10 years during which the virus remains latent. Stage III is the progressive generalized lymphadenopathy (PGL) stage, which involves 1 or more extra-inguinal lymph nodes, with nodes being more than 1 centimeter, not matted, and persisting for more than 3 months duration. Stage IV is the stage of symptomatic HIV infection during which the patient suffers from various opportunistic infections involving the lymph nodes too. Hence, lymphadenopathy remains the most consistent sign throughout the clinical course of HIV infection.
Lymph node abnormalities found in HIV-positive patients can be of various types: PGL, tuberculous lymphadenitis, florid reactive lymphadenitis, malignant lymphomas, Kaposi's sarcoma, and opportunistic fungal lymphadenitis. 3 During the past few years, several manuscripts have been published dealing with morphological and histological findings in lymph nodes of patients with AIDS. [4] [5] [6] [7] As is evident, all these studies were conducted on lymphadenopathy patients who were known HIV-positive individuals. The importance and uniqueness of the present study lie in the fact that it was conducted on those patients who were suffering from lymphadenopathy, and the HIV status was not known in these patients. Therefore, the present study was aimed at finding out hidden HIV-positive cases from a sea of probables in the community and offering them counseling and treatment wherever possible.
Material and Methods
Over a period of 6 years (2000-2005) , the study consisted of a total of 1082 cases attending the outpatient departments of various faculties in the Pt. B. D. Sharma Postgraduate Institute of Medical Sciences (PGIMS), Rohtak, Haryana, India, and presenting primarily with extra-inguinal lymphadenopathy. After informed consent, the blood sample was collected from each patient and subjected to HIV testing by 3 screening tests, that is, enzyme linked immuno-sorbent assay\rapid\simple tests (HIV EIA, Labsystems, Helsinki, Finland; HIV TRIDOT, J Mitra & Co and Ltd., New Delhi, India; and Capillus HIV-1/HIV-2, Cambridge Diagnostics, Galway, Ireland).
Simultaneously, fine needle aspiration cytology of the lymph nodes was performed at 3 sites in the palpable lymph nodes (more than 1 cm in diameter) with 22-gauge needle and syringe. 8 The extrainguinal lymph nodes, preferably enlarged cervical and axillary group of lymph nodes, were included in the present study. The inguinal lymph node were excluded to remove the bias of their involvement in other sexually transmitted infections. Aspiration from more than 1 lymph node was performed in cases where there was multiple lymph node enlargement as well as where more than 1 group of lymph nodes was enlarged (30.6%). In 186 (17.2%) cases (102 malignant lymphadenopathy cases for confirmation and further typing of malignancy, and 84 granulomatous lymphadenitis cases for confirmation of tuberculous and nontuberculous lymphadenitis), excisional biopsy was performed during the follow-up of the patients.
Following aspiration, 1 part of the aspirated material was subjected to culture for mycobacteria on 2 slants of Lowenstein-Jensen (LJ) medium. 9 For isolation of other bacteria, the aspirate was inoculated on blood and MacConkey agar, and Sabouraud's dextrose agar was inoculated for isolation of fungi. These media were incubated at 37°C for 2 to 10 weeks, 37°C for 48 hours, and 25°C for 6 to 8 weeks, respectively. 10, 11 From the other part of the aspirate, smears were prepared on clean glass slides and stained with Leishmann, Haematoxylin & Eosin, Gram, and Ziehl-Neelsen (ZN) stainings. Potassium hydroxide and India ink mounts were also prepared for fungal isolates. 12 The smears were examined microscopically. The cause of lymphadenopathy was determined on the basis of microscopic examination of the stained smears, cultural and biochemical characteristics, and cytopathological studies.
Results
Depending on the cytopathological and the microbiological diagnosis made on the aspirates, all 1082 cases were divided into 5 major categories, that is, reactive lymphadenitis, granulomatous lymphadenitis, pyogenic lymphadenitis, fungal lymphadenitis, and malignancies (Table 1) . Granulomatous lymphadenitis was further divided into tuberculous and nontuberculous lymphadenitis depending on the results of ZN staining and culture on LJ medium.
Cervical lymphadenopathy was seen in 643 (59.4%) cases, axillary lymphadenopathy in 271 (25.0%) cases, and enlargement of both cervical and axillary lymph nodes was seen in 168 (15.6%) cases. HIV = human immunodeficiency virus; + = positive; -= negative; AFB = acid-fast bacilli; LJ = Lowenstein-Jensen medium; S. pyogenes = Streptococcus pyogenes; S. aureus = Staphylococcus aureus; K. pneumoniae = Klebsiella pneumoniae; P. aeruginosa = Pseudomonas aeruginosa; E. coli = Escherichia coli; sp. = species.
The incidence of HIV positivity was found to be 2.3% among the lymphadenopathy cases. Because no such study has been conducted anywhere so far, no data were available for comparison. There could have been a possibility of a higher incidence of HIV infection if the retesting of once-HIV-negative lymphadenopathy cases had been done in the subsequent weeks.
Out of 25 HIV-positive cases, 15 were males and 10 were females, and 48% of HIV-positive cases belonged to third decade, followed by fourth decade (36%). The youngest patient was 20 years old, and the oldest was 50 years old. Fifteen (60%) cases had tuberculous lymphadenopathy. This incidence was significantly higher than in HIV-negative cases (28%). Many studies have been conducted to study the association between HIV and tuberculosis, and over the past few years, tuberculosis has emerged as one of the most common opportunistic infections in patients seropositive for HIV-1. 13 Although infection by atypical mycobacteria has attracted much clinical attention in developed countries, in developing countries like ours, infection with Mycobacterium tuberculosis is still much more frequently seen in HIV patients as compared to atypical mycobacteria as observed in a previous 16-year study. 14 Besides highlighting the higher incidence of HIV positivity in previously unsuspected patients of lymphadenopathy, the present study made many other important observations, for some of which data were available for comparison.
Of the 1082 lymphadenopathy cases, 328 (31%) cases were of nonspecific reactive lymphadenopathy whereas 524 (49%) cases were of granulomatous lymphadenopathy. These findings were comparable to the study by Krishnaswami et al, who reported 28% cases of reactive and 48% cases of granulomatous lymphadenopathy from the total of 265 lymphadenopathy cases. 15 In the category of malignancies of the lymph nodes including carcinomas, Hodgkin's lymphoma, and non-Hodgkin's lymphoma, an increased incidence was found in males than in females, a finding in conformity with the studies previously conducted on lymph node malignancies. [16] [17] [18] A more interesting observation sprung out from the study when HIV positivity was calculated on yearly basis. It was 0.6% in the year 2000 and steadily climbed to 2.8% in the year 2005 (through the end of October). Comparing these results with the trend of HIV infection over the past 6 years in the Haryana state as depicted by the sentinel surveillance carried out by the National AIDS Control Organization (NACO), 19 contrasting results were observed (Table 2, Figure 1) , 19, 20 with the NACO sentinel surveillance showing a downward trend of HIV infection in the antenatal case (ANC) group and the sexually transmitted disease (STD) group, whereas the present study results show an increase in the incidence of HIV infection in the community. However, HIV positivity was not homogenous over the 6 years in all 3 groups and was not found to be statistically significant (chi-square test used).
Conclusion
According to the available data, there were about The incidence of HIV infection in the ANC group of NACO's sentinel surveillance in the Haryana state of India, a category taken as the proxy for the general population, has been seen to decline to a mere 0.24% in the year 2005 (as per NACO's sentinel surveillance), which confirms a comfortable place for the Haryana state in a low prevalence group. But taking into account the global, as well as the national, gender distribution of HIV infection, males supersede females. Thus, it would be highly optimistic to rely completely on the sentinel surveillance results, which depict the HIV incidence in only the female population in the community, if taking into consideration the ANC group as the representation of the general population. Moreover, failure of the trials for detecting HIV incidence by screening of ANC attendees and STD cases conducted in Tanzania and Uganda 22 bolsters our claim of needing to search for more reliable indicators to estimate the exact incidence of HIV infection in the community.
The most important matter of concern is that out of all the estimated cases of HIV/AIDS, only about one fourth are reported cases and the remaining, that is, a vast majority of them, remain hidden and undiagnosed, still at large transmitting the infection to a much larger cross-section of the society. The main purpose of the present study was to detect and diagnose such hidden cases. With complete treatment and vaccination of HIV infection being a far-fetched possibility and prevention being the only resort to curb this ever-growing epidemic, the present study urges much greater vigilance and caution on the part of the clinicians while dealing with outdoor patients presenting with lymphadenopathy. They should always keep in mind the possibility of HIV positivity, even though remote in many cases, so that transmission of this deadly disease from this significant minority of patients to the clinician and also to a much larger population at risk can be avoided. 
